Home / Inspections / 840164

FDA Inspection 840164 — Corden Pharma Colorado, Inc.

Corden Pharma Colorado, Inc. — FEI 1710165

The FDA completed an inspection of Corden Pharma Colorado, Inc. on June 28, 2013 in Boulder, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 28, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boulder, CO (United States)

Facility

Other inspections at this facility

  • 1294814 (NAI Fri Nov 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1081516 (VAI Wed Feb 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1052209 (NAI Fri Mar 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988484 (VAI Mon May 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 977464 (NAI Fri Feb 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources